Alpha 1-antitrypsin deficiency Trials in Denver, United States
Conditions / Alpha 1-antitrypsin deficiency / Denver, United States
Alpha 1-antitrypsin deficiency has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00301366 | The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency | COMPLETED | PHASE3 |
| NCT06505603 | PiMZ Longitudinal Cohort (PiMZ Logic) | RECRUITING | — |
| NCT05897424 | Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema | RECRUITING | PHASE2 |
| NCT05856331 | Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema | COMPLETED | PHASE2 |
| NCT04167345 | Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype | TERMINATED | PHASE2 |
| NCT00532805 | The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency | COMPLETED | — |
| NCT00295061 | Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults | COMPLETED | PHASE3 |
| NCT05297812 | Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease | ACTIVE_NOT_RECRUITING | — |
| NCT01419158 | Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | — |
| NCT01832220 | Genomic Research in Alpha-1 Antitrypsin Deficiency | COMPLETED | — |